Hibiya S - Search Results

1

COVID-19 severity is associated with the risk of gastrointestinal bleeding.

Hibiya S, Fujii T, Fujii T, Suzuki S, Kondo M, Ooka S, Furumoto Y, Azuma S, Tanaka K, Kurata H, Tanaka S, Kurosaki M, Nagayama K, Kusano F, Iizuka Y, Kawamura T, Ikemiyagi H, Sakita S, Yauchi T, Watanabe H, Kawamoto A, Matsuyama Y, Ohtsuka K, Okamoto R. Hibiya S, et al. BMJ Open Gastroenterol. 2023 Nov;10(1):e001199. doi: 10.1136/bmjgast-2023-001199. BMJ Open Gastroenterol. 2023. PMID: 37963649 Free PMC article.

2

Mucosal healing of small intestinal stricture is associated with improved prognosis post-dilation in Crohn's disease.

Hibiya S, Ohtsuka K, Takenaka K, Kawamoto A, Matsuyama Y, Udagawa Y, Motobayashi M, Shimizu H, Fujii T, Saito E, Nagahori M, Okamoto R, Watanabe M. Hibiya S, et al. BMC Gastroenterol. 2022 May 4;22(1):218. doi: 10.1186/s12876-022-02300-2. BMC Gastroenterol. 2022. PMID: 35508963 Free PMC article.

3

5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis.

Hibiya S, Matsuyama Y, Fujii T, Maeyashiki C, Saito E, Ito K, Shimizu H, Kawamoto A, Motobayashi M, Takenaka K, Nagahori M, Kurosaki M, Yauchi T, Ohtsuka K, Fujiwara T, Okamoto R, Watanabe M. Hibiya S, et al. Aliment Pharmacol Ther. 2021 Jan;53(1):103-113. doi: 10.1111/apt.16120. Epub 2020 Nov 7. Aliment Pharmacol Ther. 2021. PMID: 33159485

4

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus.

Shimizu H, Fujii T, Kinoshita K, Kawamoto A, Hibiya S, Takenaka K, Saito E, Nagahori M, Ohtsuka K, Watanabe M, Okamoto R. Shimizu H, et al. Among authors: hibiya s. BMC Gastroenterol. 2021 Dec 23;21(1):494. doi: 10.1186/s12876-021-02043-6. BMC Gastroenterol. 2021. PMID: 34949172 Free PMC article.

5

A case of venous stasis colitis possibly caused by eplerenone.

Saito E, Ohtsuka K, Kawamoto A, Fujii T, Takenaka K, Hibiya S, Shimizu H, Nagahori M, Tomii S, Okamoto R. Saito E, et al. Among authors: hibiya s. Clin J Gastroenterol. 2023 Feb;16(1):69-72. doi: 10.1007/s12328-022-01722-5. Epub 2022 Nov 1. Clin J Gastroenterol. 2023. PMID: 36319777

6

Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.

Takenaka K, Kawamoto A, Hibiya S, Suzuki K, Fujii T, Motobayashi M, Shimizu H, Nagahori M, Saito E, Okamoto R, Watanabe M, Ohtsuka K. Takenaka K, et al. Among authors: hibiya s. Aliment Pharmacol Ther. 2021 Oct;54(8):1052-1060. doi: 10.1111/apt.16551. Epub 2021 Jul 29. Aliment Pharmacol Ther. 2021. PMID: 34323301

7

Deep neural network for video colonoscopy of ulcerative colitis: a cross-sectional study.

Takenaka K, Fujii T, Kawamoto A, Suzuki K, Shimizu H, Maeyashiki C, Yamaji O, Motobayashi M, Igarashi A, Hanazawa R, Hibiya S, Nagahori M, Saito E, Okamoto R, Ohtsuka K, Watanabe M. Takenaka K, et al. Among authors: hibiya s. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):230-237. doi: 10.1016/S2468-1253(21)00372-1. Epub 2021 Nov 29. Lancet Gastroenterol Hepatol. 2022. PMID: 34856196

8

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.

Takenaka K, Kitazume Y, Kawamoto A, Fujii T, Udagawa Y, Wanatabe R, Shimizu H, Hibiya S, Nagahori M, Ohtsuka K, Sato H, Hirakawa A, Watanabe M, Okamoto R. Takenaka K, et al. Among authors: hibiya s. Am J Gastroenterol. 2023 Jun 1;118(6):1028-1035. doi: 10.14309/ajg.0000000000002127. Epub 2022 Dec 23. Am J Gastroenterol. 2023. PMID: 36571769

9

Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission.

Kaneshiro M, Takenaka K, Suzuki K, Fujii T, Hibiya S, Kawamoto A, Motobayashi M, Shimizu H, Nagahori M, Saito E, Okamoto R, Ohtsuka K, Watanabe M. Kaneshiro M, et al. Among authors: hibiya s. Aliment Pharmacol Ther. 2021 Apr;53(8):900-907. doi: 10.1111/apt.16310. Epub 2021 Mar 1. Aliment Pharmacol Ther. 2021. PMID: 33645736

10

Serum Leucine-Rich α₂ Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn's Disease.

Kawamoto A, Takenaka K, Hibiya S, Ohtsuka K, Okamoto R, Watanabe M. Kawamoto A, et al. Among authors: hibiya s. Clin Gastroenterol Hepatol. 2022 May;20(5):e1196-e1200. doi: 10.1016/j.cgh.2021.06.036. Epub 2021 Jun 30. Clin Gastroenterol Hepatol. 2022. PMID: 34216822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page